
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Therapy: Preclinical |
Authors' Affiliations: Departments of 1 Oral Diagnostic Service, 2 Biochemistry and Molecular Biology, and 3 Radiation Oncology, and 4 Cancer Center, Howard University, Washington, District of Columbia; 5 Shanghai TenGen Biomedical Co. Ltd., Shanghai, China; 6 Experiment Center, Binzhou Medical College, Shandong, China; 7 Oriental TenGen Tech Development Co. Ltd., Beijing, China; and 8 Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland
Requests for reprints: Xinbin Gu, Department of Oral Diagnostic Service, College of Dentistry, Howard University, 600 W Street, NW, Washington, DC 20059. Phone: 202-806-0345; Fax: 202-806-0446. E-mail: xgu{at}howard.edu.
Purpose: Vitamin E succinate (
-TOS) inhibits the growth of cancer cells without unacceptable side effects. Therefore, the mechanisms associated with the anticancer action of
-TOS, including ceramide-mediated apoptosis, were investigated using head and neck squamous cell carcinoma (HNSCC) in vitro and in vivo.
Experimental Design: Five different human HNSCC cell lines (JHU-011, JHU-013, JHU-019, JHU-022, and JHU-029) were treated with
-TOS, and its effects on cell proliferation, cell cycle progression, ceramide-mediated apoptosis, and ceramide metabolism were evaluated. The anticancer effect of
-TOS was also examined on JHU-022 solid tumor xenograft growth in immunodeficient mice.
Results:
-TOS inhibited the growth of all the HNSCC cell lines in vitro in a dose- and time-dependent manner. Thus, JHU-013 and JHU-022 cell lines were more sensitive to
-TOS than the other cell lines. Cellular levels of ceramide, sphingomyelinase activity, caspase-3, and p53 were elevated with increasing time of exposure to
-TOS. The degradation of poly(ADP-ribose) polymerase protein in JHU-022 cells treated with
-TOS provided evidence for apoptosis. The amounts of nuclear factor
B, Bcl-2, and Bcl-XL proteins were reduced in the cells treated with
-TOS for 6 hours. The levels of caspase-9, murine double minute-2, and I
B-
proteins were unchanged after
-TOS treatment. I.p. administration of
-TOS slowed tumor growth in immunodeficient mice.
Conclusions:
-TOS showed promising anticancer effects to inhibit HNSCC growth and viability in vivo and in vitro. The induction of enzymes involved in ceramide metabolism by
-TOS suggests that ceramide-mediated apoptosis may expand therapeutic strategies in the treatment of carcinoma.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |